Clinical features and outcome in 25 dogs with respiratory-associated pulmonary hypertension treated with sildenafil.

Sildenafil responsiveness is variable in dogs with respiratory-associated PH, but improved QOL was demonstrated in dogs surviving >1 month, and long-term survival was noted in some cases.